Table 1.
Clinical characteristics of children and adolescents presenting with symptoms and signs of Kawasaki disease during the coronavirus disease 2019 pandemic. Values are numbers (percentages) unless stated otherwise
| Characteristics | Total (n=21) |
|---|---|
| Personal: | |
| Median (range) age (years) | 7.9 (3.7-16.6) |
| Girls | 12 (57) |
| Parents country of birth (n=42): | |
| Sub-Saharan Africa/Caribbean islands | 24 (57) |
| Asia | 4 (10) |
| Europe | 12 (29) |
| Middle East | 2 (5) |
| Kawasaki disease principal clinical criteria: | |
| Complete presentation (fever >4 days and ≥4 principal criteria) | 11 (52) |
| Lips and oral cavity changes | 16 (76) |
| Bilateral bulbar conjunctival injection | 17 (81) |
| Rash | 16 (76) |
| Changes to extremities | 10 (48) |
| Cervical lymphadenopathy | 12 (57) |
| Median (range) days of fever before intravenous immunoglobulin | 5 (0-12) |
| Kawasaki disease associated clinical features: | |
| Gastrointestinal symptoms | 21 (100) |
| Perineal or face desquamation | 4 (19) |
| Arthralgia | 2 (10) |
| Irritability | 12 (57) |
| Other neurological features | 6 (29) |
| Myocarditis | 16 (76) |
| Median (range) left ventricular ejection fraction rate | 42 (10-57) |
| Serous effusion | 12 (57) |